Biopharmx and timber case study
Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO A REVERSE MERGER BETWEEN BIOPHARMX AND TIMBER PHARMACEUTICALS Situation Assessment A wholly-owned subsidiary […]
Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO A REVERSE MERGER BETWEEN BIOPHARMX AND TIMBER PHARMACEUTICALS Situation Assessment A wholly-owned subsidiary […]
Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO $30M EQUITY RAISE Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in connection with Celgene’s acquisition
Transaction Case Studies Chinese Joint Venture to Facilitate Indication Expansion Opportunity Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in
Transaction Case Studies MANA THERAPEUTICS: ROBUST DUAL-TRACK PROCESS TO A SUCCESSFUL $35M SERIES A FINANCING Situation Assessment Mana Therapeutics is
Transaction Case Studies SELL-SIDE ENGAGEMENT FOR GRITSTONE LEADING TO A PARTNERSHIP WITH GILEAD FOR $60M UPFRONT AND $725M IN ADDITIONAL
Transaction Case Studies RAPID FINANCING PROCESS LED TO OVERSUBSCRIBED CROSSOVER FINANCING Situation Assessment C4 Therapeutics is a private biotech with
Transaction Case Studies IPO Advisory assignment helping raise $210M in a NASDAQ IPO Situation Assessment Following the completion of a
Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private
Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,